But one man bucking the trend is the adventurous businessman Nat Rothschild, who revealed he is tapping the market for cash in order fund a takeover at Volex. But investors were not so sure and shares fell 1.2 per cent, or 3p, to 252p. But shares fell as investors worried further inflation fears would soon bite. The pharmaceutical giant revealed results from a clinical trial, which included 25,000 people. Shares fell 0.9 per cent, or 12.8p, to 1359p.

Source: Daily Mail June 23, 2023 13:39 UTC